1-20 of 545
Sort by
News

FDA Approves R/R FL Treatment

Published: 2024
Abstract
September 2024
View News titled, FDA Approves R/R FL Treatment
News

NEJM Rescinds Policy Limiting Advanced Access for Embargoed Content

Published: 2024
Abstract
August 2024
View News titled, NEJM Rescinds Policy Limiting Advanced Access for Embargoed Content
News

Hemophilia B Treatment Receives Orphan Drug Designation

Published: 2024
Abstract
July 2024
View News titled, Hemophilia B Treatment Receives Orphan Drug Designation
News

FDA Approves MDS Treatment

Published: 2024
Abstract
September 2024
View News titled, FDA Approves MDS Treatment
News

MM Treatment Granted Priority Review

Published: 2024
Abstract
September 2024
View News titled, MM Treatment Granted Priority Review
News

FDA Approves Biosimilar for Rare Diseases

Published: 2024
Abstract
July 2024
View News titled, FDA Approves Biosimilar for Rare Diseases
News

R/R MCL Treatment Receives FDA Approval

Published: 2024
Abstract
September 2024
View News titled, R/R MCL Treatment Receives FDA Approval
News

Joint Commission to Launch Telehealth Accreditation Program

Published: 2024
Abstract
August 2024
View News titled, Joint Commission to Launch Telehealth Accreditation Program
News

FDA Clears AI Diagnostic Tool for Hematologic Conditions

Tess Stafford
Published: 2024
Abstract
Mid-July 2024
View News titled, FDA Clears AI Diagnostic Tool for Hematologic Conditions
News

Medicare to Cover alloHCT

Published: 2024
Abstract
August 2024
View News titled, Medicare to Cover alloHCT
News

R/R FL Treatment Receives FDA Accelerated Approval

Published: 2024
Abstract
August 2024
View News titled, R/R FL Treatment Receives FDA Accelerated Approval
News

FDA Approves Four Hematologic Treatments

Tess Stafford
Published: 2024
Abstract
July 2024
View News titled, FDA Approves Four Hematologic Treatments
News

FDA’s BPAC Evaluates Use of NAT to Reduce the Risk of Transfusion-Transmitted Malaria

Claire Whetzel
Published: 2024
Abstract
May 2024
View News titled, FDA’s BPAC Evaluates Use of NAT to Reduce the Risk of Transfusion-Transmitted Malaria
News

ABIM Announces Specialized Hematology LKAs

Published: 2024
Abstract
June 2024
View News titled, ABIM Announces Specialized Hematology LKAs
News

FDA Withdraws MM Treatment from Market

Published: 2024
Abstract
June 2024
View News titled, FDA Withdraws MM Treatment from Market
News

FDA Approves R/R ALL Treatment

Published: 2024
Abstract
June 2024
View News titled, FDA Approves R/R ALL Treatment
News

Denosumab Biosimilars Receive FDA Approval

Published: 2024
Abstract
June 2024
View News titled, Denosumab Biosimilars Receive FDA Approval
News

FDA Grants GVHD Treatment Priority Review

Published: 2024
Abstract
June 2024
View News titled, FDA Grants GVHD Treatment Priority Review
News

FDA Accepts CML Drug Submission Following Rejection

Published: 2024
Abstract
May 2024
View News titled, FDA Accepts CML Drug Submission Following Rejection
News

Beta Blocker to Be Evaluated in SCD

Published: 2024
Abstract
May 2024
View News titled, Beta Blocker to Be Evaluated in SCD